Prof. Doreen Addrizzo-Harris
United States
Prof. Doreen Addrizzo-Harris (United States)
Doreen J. Addrizzo-Harris, MD, FCCP, is a pulmonary/critical care physician with an extensive background in bronchiectasis and non-tuberculous mycobacterial infection and medical education. Dr. Addrizzo-Harris is currently a Professor of Medicine at the NYU Grossman School of Medicine. She serves as the Associate Division Director for Clinical and Faculty Affairs, is the Director of the NYU Bronchiectasis and NTM Program, and is Co-Director of the NYU Pulmonary Faculty Practice. She is now serving in her 20th year as the Program Director of NYU’s Pulmonary and Critical Care Medicine Fellowship.
Dr. Addrizzo-Harris received her medical degree and completed her residency and fellowship training at New York University School of Medicine. Since completing her training, she was recruited to stay as a faculty member at NYU, where she has been a critical presence over the past 25 years. She has been instrumental in educating the next generation of pulmonary/critical care physicians and has won a number of awards for her teaching skills, most recently, the 2020 first place Program Director of the ATS Best Practice Program. Dr. Addrizzo-Harris has served on the board of the Association of Pulmonary and Critical Care Medicine Program Directors (APCCMPD), including serving as President from 2006-2007. Academically she authored 39 peer-reviewed publications and 54 scientific abstracts presented at international conferences. She has participated in numerous clinical trials, many as PI. Dr. Addrizzo-Harris has been recognized as a Distinguished CHEST Educator each year since its inception since 2017 and received the Distinguished Service Award in 2019.
During her leadership tenure with CHEST, Dr. Addrizzo-Harris has served on the Marketing Committee, the Health and Science Policy Committee (Chair from 2007-2009), Government Relations Committee, Scientific Program Committee, Education Committee, Governance Committee, Editorial Board for CHEST Physician, Professional Standards Committee (Chair 2016-2018), Board of Regents, and CHEST Foundation Board of Trustees. Most recently, Dr. Addrizzo-Harris served as the President of the CHEST Foundation from 2018-2019 and Co-Chair of the Foundation Awards Committee from 2015-2020. Dr. Addrizzo-Harris will serve as the sixth women to lead the American College of Chest Physicians.
Dr. Sita Andarini
Indonesia
Dr. Sita Andarini (Indonesia)
Dr. Sita Andarini is currently academic staff and Consultant at Division of Thoracic Oncology and Division of Respiratory Immunology and Interstitial Lung Disease, Department of Pulmonology and Respiratory Medicine, Faculty of Medicine University of Indonesia – Persahabatan Hospital. After completing her MD and Pulmonologist at Faculty of Medicine University of Indonesia, she obtained PhD in Tohoku University, Japan. She is currently head of Thoracic Oncology Indonesian Society of Respirology, Head of Assembly of Lung Cancer for Asian Pacific Society of Respirology, and member of International Association for the Study of Lung Cancer. Her interest includes thoracic oncology especially immuno-oncology and driver oncogene, and interstitial lung diseases. She involves in several clinical research of lung cancer and interstitial lung disease. She published several papers, receiving research grants and awards in lung cancer and interstitial lung disease.
Prof. John Balmes
United States
Prof. John Balmes (United States)
Dr. Balmes is Professor of Medicine Emeritus at the University of California, San Francisco (UCSF) and Professor of Environmental Health Sciences Emeritus in the School of Public Health at the University of California, Berkeley (UC Berkeley). He is an Attending Physician in the UCSF Division of Occupational, Environmental and Climate Medicine and the Division of Pulmonary and Critical Care Medicine at the Zuckerberg San Francisco General Hospital. At UC Berkeley, he is one of the Principal Investigators of the Children’s Health and Air Pollution Study (CHAPS) in Fresno, California. Dr. Balmes has been studying the effects of occupational and environmental agents on respiratory, cardiovascular, and metabolic health for over 40 years. He was appointed Physician Member of the California Air Resources Board in 2008.
Prof. Philip Bardin
Australia
Prof. Philip Bardin (Australia)
Phil Bardin is Professor of Respiratory Medicine in the Faculty of Medicine, Nursing & Health Sciences, Monash University, Melbourne, Australia. Since 2008 he has been Director, Lung Sleep Allergy & Immunology, Monash University and Medical Centre, Melbourne.
He is recognised for investigation of obstructive lung diseases (particularly virus-asthma-COPD exacerbations) and has conducted extensive research of new asthma and COPD therapies. Recently research has also focussed on vocal cord dysfunction in obstructive lung diseases. He is a recipient of ongoing Australian NH&MRC funding, has chaired the Australian NH&MRC Grant Review Panel (Respiratory & Sleep Medicine) and served on the Australian NH&MRC Academy. His professional activities reflect a career-long commitment to research and medical education, particularly in the areas of asthma and COPD.
Currently he is co-Editor-in-Chief of Respirology, official journal of the TSANZ and APSR.
Dr. Imran Bin Mohamed Noor
Singapore
Dr. Imran Bin Mohamed Noor (Singapore)
Dr Imran Bin Mohamed Noor
Senior Consultant
Lead Pleural Physician
Changi General Hospital
Singapore
Dr Imran Bin Mohamed Noor graduated from the National University of Singapore, Faculty of Medicine in 1998. He obtained his MRCP in 2003. He completed his 3-year training in Respiratory Medicine in 2007. In 2010, he did a one year fellowship under the HMDP programme in Sir Charles Gairdner Hospital. This included a 6-month training in pleural diseases under the guidance of Prof Gary Lee. Upon completion of his fellowship, Dr Imran has been pivotal in the establishment of a pleural service in Changi General Hospital. The service oversees the management of pleural disease within the hospital, from pneumothorax to pleural effusions. This include inpatient services as well as outpatient services like pleural clinic and post-discharge community service for patients with indwelling pleural catheter. He currently serves as the lead pleural physician for the Department of Respiratory & Critical Care Medicine in Changi General Hospital.
Prof. Laurent Brochard
Canada
Prof. Laurent Brochard (Canada)
Pr. Laurent Brochard is Intensivist, Clinician Scientist, St. Michael’s Hospital (Unity Health Toronto) and Director of the Interdepartmental Division of Critical Care Medicine, University of Toronto, Canada, since 2014. He holds the Keenan Chair in Critical Care and Acute Respiratory failure.
He trained in respirology and critical care, obtained his MD degree, University of Paris, and worked in Assistance Publique-Hôpitaux de Paris (Hôpital Henri Mondor, Creteil) until he moved to Geneva University Hospital, Switzerland (2010-2013) before being recruited in Toronto.
He has been Editor-in-Chief of Intensive Care Medicine, is currently Deputy Editor of the American Journal of Respiratory and Critical Care Medicine.
He created a clinical research network on mechanical ventilation REVA. He leads an international group on respiratory physiology (PLUG) and leads the Centre of Excellence in Mechanical Ventilation in Toronto (CoEMV).
He mentored and directed numerous trainees, many of whom are leaders in Critical Care. He published over > 700 peer-reviewed publications (H-index 123).
Prof. Louis Chai
Singapore
Prof. Louis Chai (Singapore)
Dr. Louis Chai is Senior Consultant Infectious Diseases Physician and Associate Professor in the Department of Medicine, National University Health System, Singapore, as well as Principal Investigator, Opportunistic Infections Group, Division of Infectious Diseases, NUHS. Dr Chai’s interests lie in fungal, opportunistic and atypical infections in immunocompromised hosts, patients with altered immunity and host-pathogen interaction. These are also the themes of his research group. He remains deeply entrenched at the bedside in providing clinical service for general infectious diseases and internal medicine. Dr Chai is funded by the National Medical Research Council of Singapore and the National University Health System.
Prof. James Chalmers
United Kingdom
Prof. James Chalmers (United Kingdom)
Professor James D Chalmers is Asthma and Lung UK Chair of Respiratory Research at the University of Dundee and a Consultant Respiratory Physician. His clinical and research interests are in difficult respiratory infections, particularly bronchiectasis, COPD and COVID-19. His research group is particularly focused on novel non-antibiotic approaches to treating chronic lung inflammation, and he leads several international trials of novel therapeutics. He is chair of the Science and Research Committee of the British Thoracic Society and is Chief editor of the European Respiratory Journal. He has chaired multiple international guidelines and is current chair of the European Bronchiectasis Registry.
Dr. Adrian Kwok Wai Chan
Singapore
Dr. Adrian Kwok Wai Chan (Singapore)
Dr Chan Kwok Wai Adrian is a consultant respiratory physician, allergy specialist and intensivist at Mount Elizabeth Novena Hospital. Dr Chan is actively involved in various professional committees, including secretary and executive committee member for the Singapore Thoracic Society, as well as executive committee member for the Allergy and Clinical Immunology Society of Singapore. He is also the current president of the Asthma and Allergy Association of Singapore.
Dr. Amy Chan
New Zealand
Dr. Amy Chan (New Zealand)
Dr Amy Chan is senior clinical academic at the University of Auckland, New Zealand, working clinically in primary care. Amy also holds an honorary post at the Centre of Behavioural Medicine, University College London, UK and is affiliated with the Asthma UK Centre of Applied Research. For over 15 years, Amy has been conducting research into the intersection between adherence, digital technologies and asthma management, including how technologies can be used to promote medication adherence and improve asthma outcomes using big data and innovative technologies. Amy has experience applying her research to improve asthma care through providing consultancy to charities, medical research organisations, and non-government organisations. Amy is the global lead for workforce transformation with the International Pharmaceutical Federation (FIP), working group lead for the European Respiratory Society Clinical Research Collaboration CONNECT, and member of the Respiratory Effectiveness Group, Open Digital Health, PSA Respiratory Taskforce and Asthma NZ board.
A/Prof. Cynthia Chee
Singapore
A/Prof. Cynthia Chee (Singapore)
Dr Chee graduated from the National University of Singapore (NUS) in 1984. She obtained the Membership of the Royal College of Physicians (Edinburgh), and Masters of Medicine (Internal Medicine) from the School of Postgraduate Medicine, NUS in 1989. She trained as an adult Respiratory Physician and was granted the Fellowship of the Royal College of Physicians (Edinburgh) in 1999. She was involved in the setting up of the Ministry of Health Singapore TB Elimination Programme (STEP) in 1997 and in implementing its initiatives for over twenty years. She was Director of STEP and the TB Control Unit from January 2018 to September 2019. She has published over 100 articles in medical peer-reviewed journals.
Dr. Ning-Hung Chen
Taiwan
Dr. Ning-Hung Chen (Taiwan)
Professor Chen is a full Professor and attending physician of Chang Gung University and Chang Gung Memorial Hospital, Taiwan. He was trained in sleep medicine at Stanford Sleep Disorders Clinic and the Division of sleep medicine, Center for Sleep and Respiratory Neurobiology-CSRN in Philadelphia.
Dr. Chen was the founder of Sleep Center in Chang Gung Memorial Hospital. He has served as the 3rd President of Taiwan Society of Sleep Medicine, Secretary General of World Sleep Federation, Vice President of Asian Sleep Research Society, President of Asian Society of Sleep Medicine and now the head of the Assembly of Neurobiology and Sleep of APSR.
Dr. Chen published more than 180 SCI articles, two books, and owns several patents about sleep. He won the Fukuchi Award of APSR in 2018 and was named as world’s top 2% Scientists jointly published by Elsevier BV and Stanford University in 2020 and 2021.
Dr. May Anne Cheong
Singapore
Dr. May Anne Cheong (Singapore)
Dr Cheong May Anne is a Consultant in the Department of Haematology, Singapore General Hospital. She received the NUS Undergraduate (Merit) Scholarship to read Medicine at the National University of Singapore and graduated in 2012. She completed her Internal Medicine training at Singhealth in 2017, where she served as Chief Resident. She completed specialist training in Haematology at Singhealth in 2020 and obtained her FRCPath (Haematology) in 2019. May Anne has a subspeciality interest in thrombosis and haemostasis and leads the cancer associated thrombosis service at the National Cancer Centre, Singapore and a founding member of the pulmonary embolism response team at Singapore General Hospital.
A/Prof. Fook Tim Chew
Singapore
A/Prof. Fook Tim Chew (Singapore)
Dr CHEW Fook Tim is Vice Dean of the Faculty of Science, National University of Singapore (NUS), overseeing the Undergraduate and International Programs. He also oversees the Curriculum of the combined College of Humanities and Sciences (CHS) at NUS. He is also an Associate Professor at the Department of Biological Sciences teaching both Undergraduate and Postgraduate Molecular Genetics and Immunology; and is the Principal Investigator of the Functional Genomics Laboratories, Molecular Immunology and Allergy Lab, and the Molecular Breeding Lab at the NUS Agritech Centre. His key areas of research are in the Genetics and Epidemiology of Allergic and Skin Diseases, as well as the Characterization of Allergenic Components, where he has published >200 scientific articles and reviews. He is the lead scientific consultant to Biomedical and Agri-Science companies and is on the Governing Board of several major organizations.
Dr. Puey Ling Chia
Singapore
Dr. Puey Ling Chia (Singapore)
Dr Chia Puey Ling is a Medical Oncology Consultant at Tan Tock Seng Hospital with subspecialty interest in thoracic and genitourinary oncology.
After completing her basic physician training in Singapore and obtaining membership of the Royal Colleges of Physicians of the United Kingdom (MRCP) and Master of Medicine (Int. Med) Singapore, she subsequently underwent advanced specialist training in Medical Oncology in Melbourne, Australia. She obtained the fellowship of the Royal Australasian College of Physicians (FRACP) with specialty training in Medical oncology completed in 2014 and went on to pursue further PhD research related to thoracic oncology which is her field of interest.
She received the International Association for the Study of Lung Cancer (IASLC) Fellowship Award and the University of Melbourne Postgraduate Award and completed a PhD research on the study of tumour microenvironment and biomarkers in malignant mesothelioma for oncogenic targeted therapies.
She is the principle investigator or co-investigator for several international multi-centre cancer clinical trials including novel immunotherapy, targeted agents and drugs in early phase development. She has also published numerous first-author papers, including the Journal of the National Cancer Institute (JNCI) and Lung Cancer Journal.
A/Prof. Naricha Chirakalwasan
Thailand
A/Prof. Naricha Chirakalwasan (Thailand)
A/Prof. Naricha Chirakalwasan is an Associate Professor of Medicine at Division of Pulmonary and Critical Care medicine, Department of Medicine, Faculty of Medicine, Chulalongkorn University and Program Director of International Sleep Medicine Fellowship.
She also holds the position of Associate Dean of International Affairs, Faculty of Medicine, Chulalongkorn University.
She is a quadruple American Boards certified in Internal Medicine, Pulmonary Medicine, Critical Care Medicine, and Sleep Medicine.
A/Prof. Naricha Chirakalwasan has published extensively in original articles as well as review articles in well recognized journals and authored several book chapters in international textbooks.
She was an organizing chairman of the 2nd ASEAN Sleep Congress conducted in Bangkok, Thailand in August 2013, and a Scientific Co-Chair of Asian Pacific Society of Respirology (APSR) Congress conducted in Bangkok, Thailand in November 2016. She is a current Secretary-General for Federation of South East Asian Sleep Medicine (FSSM) and appointed for the position of Head-Elect for Respiratory Neurobiology and Sleep Assembly of APSR.
She also received an award of “Outstanding Young Physician” in 2021 by the Royal College of Physicians of Thailand.
Dr. Xue Ning Choo
Singapore
Dr. Xue Ning Choo (Singapore)
Dr Choo Xue Ning is a Senior Consultant in the Department of Respiratory & Critical Care Medicine at Changi General Hospital. She has a Bachelor of Medicine and Surgery (M.B.B.S) and Master of Medicine (Internal Medicine) from National University of Singapore. She has been a Member of Royal Colleges of Physicians of the United Kingdom since 2010 and has been awarded Certificate of Specialist Registration in Respiratory Medicine since 2014. She is also a fellow of the Royal College of Physicians of Edinburgh since December 2021.
She has a special interest in Respiratory Medicine in airway diseases (such as asthma, COPD etc). Additionally, she has a profound interest in respiratory function and physiology and has been Director of Pulmonary Function Laboratory at Changi General Hospital since 2017. She had previously undergone a 1-year fellowship training in airway diseases and advanced lung function at the Oxford University Hospitals, United Kingdom.
A/Prof. Sanjay H. Chotirmall
Singapore
A/Prof. Sanjay H. Chotirmall (Singapore)
ASSOCIATE PROFESSOR SANJAY H CHOTIRMALL
Provost’s Chair in Molecular Medicine and Assistant Dean (Research), Lee Kong Chian School of Medicine, NTU Singapore
Consultant Respiratory Physician, Tan Tock Seng Hospital, Singapore
A/Prof Chotirmall is an internationally recognized clinician-scientist with an established translational respiratory research group at the Lee Kong Chian School of Medicine, NTU Singapore. To date, he has performed key work on endo-phenotyping pulmonary infection, including the use of next generation sequencing approaches to study the lung microbiome, in the context of chronic inflammatory respiratory diseases that have led to publications in Nature Medicine, the New England Journal of Medicine (NEJM), the Lancet Respiratory Medicine, Cell Host and Microbe and the American Journal of Respiratory and Critical Care Medicine (AJRCCM). He has been appointed Provost’s Chair in Molecular Medicine at NTU Singapore since 2019 and currently serves as Deputy Editor at the American Journal of Respiratory and Critical Care Medicine (AJRCCM).
Dr. Matthew Cove
Singapore
Dr. Matthew Cove (Singapore)
Matthew Cove completed an Internal Medicine Residency in Portland Oregon and a Critical Care Fellowship in Pittsburgh. He moved to Singapore in 2012, where he works as a Critical Care Consultant. His clinical appointment includes providing consultant cover in the Medical Intensive Care and Surgical High Dependency Units at National University Hospital Singapore. His research interests include the development of novel extracorporeal ventilation support devices and patient-ventilator interactions, particularly in those with acute respiratory distress syndrome. Since arriving in Singapore, Matthew has received funding from the National Medical Research Council to develop a research lab focused on extracorporeal respiratory support research as well as conduct clinical trials. In addition, his clinical research team are currently participating in a large international study (REMAP CAP), investigating the best treatment options for critically ill patients with pneumonia and has funding for developing novel diagnostics for fever and sepsis.
Prof. Charles L. Daley
United States
Prof. Charles L. Daley (United States)
Charles L. Daley, M.D., is Chief of the Division of Mycobacterial and Respiratory Infections at National Jewish Health (NJH) and Professor of Medicine at NJH, the University of Colorado, and Icahn School of Medicine at Mount Sinai. Prior to coming to NJH, he was medical director of the Curry Training Center at the University of California, San Francisco. Dr. Daley has served on and chaired expert panels for the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), Infectious Diseases Society of America and American Thoracic Society. He Chaired the revision of the multi-society sponsored NTM Treatment Guideline. Dr. Daley chaired the Green Light Committee, gGLC, and Global Drug Resistance Initiative (GDI) for the Stop TB Partnership and World Health Organization. For his work with MDR-TB he was awarded the World Lung Health Award by the American Thoracic Society. He was previously Associate Editor of the American Journal of Respiratory and Critical Care Medicine and The European Respiratory Journal and is now Associate Editor of Frontiers in Tuberculosis. His academic interests include TB global health policy and clinical and translational research related to TB, NTM infections and bronchiectasis.
Dr. Anantham Devanand
Singapore
Dr. Anantham Devanand (Singapore)
Associate Professor Anantham Devanand is the head of the SingHealth Duke-NUS Lung Centre.
He also has an interest in medical ethics and is serving as the vice chair of the Singapore National Medical Ethics Committee. Devanand is also a part-time PhD student at the NUS Centre for Biomedical Ethics, Yong Loo Lin School of Medicine.
Ms. Yvonne Cheng Fenelus
Singapore
Ms. Yvonne Cheng Fenelus (Singapore)
Yvonne C. Fenelus began her career as a Critical Care Respiratory Therapist at the National University Hospital in 2017, following completion of her undergraduate studies in Respiratory Therapy. Serving as a clinical educator, she has been actively involved in imparting respiratory care expertise to fellow healthcare professionals on topics including high flow oxygen therapy, tracheostomy management, and mechanical ventilation. As an active member of the Association of Respiratory Therapists (Singapore), she has organised several in-services to foster knowledge exchange and collaboration within the healthcare community. Currently, she leads a team of 22 Respiratory Therapists within her workplace and is pursuing her master’s degree in public health.
Prof. Dale Fisher
Singapore
Prof. Dale Fisher (Singapore)
Professor Dale Fisher is an Australian infectious diseases physician who first moved to the National University Hospital, Singapore in March 2003 during the SARS outbreak. He has had many leadership roles in international outbreak missions and outbreak response trainings in African and Asian countries. He was chair of the steering committee of WHO’s Global Outbreak Alert & Response Network (2018-2022). He was one of 12 international technical experts on the WHO mission to China in February 2020 to investigate the COVID-19 outbreak. In 2022, he was given a certificate for outstanding leadership by the Director General of WHO.
He is Group chief of Medicine at National University Health Systems and is the foundation chair of the National Infection Prevention and Control Committee (2014 – ongoing). He has authored over 200 peer-reviewed publications and given almost 200 invited and plenary presentations at academic meetings and conferences.